CN103083531B - Drug for treating diabetes - Google Patents
Drug for treating diabetes Download PDFInfo
- Publication number
- CN103083531B CN103083531B CN201110330663.6A CN201110330663A CN103083531B CN 103083531 B CN103083531 B CN 103083531B CN 201110330663 A CN201110330663 A CN 201110330663A CN 103083531 B CN103083531 B CN 103083531B
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- rhizoma
- diabetes
- medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 49
- 206010012601 diabetes mellitus Diseases 0.000 title claims abstract description 35
- 229940079593 drug Drugs 0.000 title abstract description 10
- 210000000582 semen Anatomy 0.000 claims abstract description 19
- 239000008517 radix Trichosanthis Substances 0.000 claims abstract description 13
- 244000183278 Nephelium litchi Species 0.000 claims abstract description 8
- 239000009636 Huang Qi Substances 0.000 claims abstract description 6
- 241000180649 Panax notoginseng Species 0.000 claims description 18
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 18
- 241000208340 Araliaceae Species 0.000 claims description 12
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 12
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 12
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 claims description 12
- 235000008434 ginseng Nutrition 0.000 claims description 12
- 241000255791 Bombyx Species 0.000 claims description 11
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 11
- 239000009286 sanguis draxonis Substances 0.000 claims description 11
- 239000000843 powder Substances 0.000 claims description 9
- 238000002360 preparation method Methods 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 8
- 241000605447 Anemarrhena Species 0.000 claims description 7
- 235000005903 Dioscorea Nutrition 0.000 claims description 7
- 241000234273 Dioscorea Species 0.000 claims description 7
- 235000000504 Dioscorea villosa Nutrition 0.000 claims description 7
- 241000212941 Glehnia Species 0.000 claims description 7
- 241001038563 Pseudostellaria Species 0.000 claims description 7
- 235000004879 dioscorea Nutrition 0.000 claims description 7
- 238000010298 pulverizing process Methods 0.000 claims description 6
- 241000545442 Radix Species 0.000 claims description 5
- 241001312519 Trigonella Species 0.000 claims description 4
- 238000001816 cooling Methods 0.000 claims description 4
- 239000000706 filtrate Substances 0.000 claims description 4
- 239000000463 material Substances 0.000 claims description 4
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 4
- 238000001035 drying Methods 0.000 claims description 3
- 238000005538 encapsulation Methods 0.000 claims description 3
- 239000007902 hard capsule Substances 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 15
- 241000255789 Bombyx mori Species 0.000 abstract 1
- 240000004638 Dendrobium nobile Species 0.000 abstract 1
- 235000002722 Dioscorea batatas Nutrition 0.000 abstract 1
- 235000006536 Dioscorea esculenta Nutrition 0.000 abstract 1
- 240000001811 Dioscorea oppositifolia Species 0.000 abstract 1
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 abstract 1
- 244000236658 Paeonia lactiflora Species 0.000 abstract 1
- 235000008598 Paeonia lactiflora Nutrition 0.000 abstract 1
- 235000002789 Panax ginseng Nutrition 0.000 abstract 1
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 235000003181 Panax pseudoginseng Nutrition 0.000 abstract 1
- 241000756042 Polygonatum Species 0.000 abstract 1
- 244000197580 Poria cocos Species 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 244000250129 Trigonella foenum graecum Species 0.000 abstract 1
- 229910052602 gypsum Inorganic materials 0.000 abstract 1
- 239000010440 gypsum Substances 0.000 abstract 1
- 239000001917 trigonella foenum graecum l. absolute Substances 0.000 abstract 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 14
- 239000008103 glucose Substances 0.000 description 14
- 230000000291 postprandial effect Effects 0.000 description 12
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Substances N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 9
- 239000008280 blood Substances 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 229940125396 insulin Drugs 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- 102000004877 Insulin Human genes 0.000 description 4
- 108090001061 Insulin Proteins 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- 230000007812 deficiency Effects 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 238000010791 quenching Methods 0.000 description 3
- 230000035922 thirst Effects 0.000 description 3
- 206010018473 Glycosuria Diseases 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 230000002218 hypoglycaemic effect Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 230000001502 supplementing effect Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 2
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 208000001380 Diabetic Ketoacidosis Diseases 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 206010020710 Hyperphagia Diseases 0.000 description 1
- 208000013016 Hypoglycemia Diseases 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000022329 Protein metabolism disease Diseases 0.000 description 1
- 208000032023 Signs and Symptoms Diseases 0.000 description 1
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 210000000227 basophil cell of anterior lobe of hypophysis Anatomy 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 208000035850 clinical syndrome Diseases 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000001610 euglycemic effect Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 231100000753 hepatic injury Toxicity 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 229940127017 oral antidiabetic Drugs 0.000 description 1
- 239000003538 oral antidiabetic agent Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 208000022530 polyphagia Diseases 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 210000001525 retina Anatomy 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 208000035408 type 1 diabetes mellitus 1 Diseases 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a drug for treating diabetes. The drug comprises, by weight, 50-70 parts of radix trichosanthis, 50-70 parts of poria cocos, 50-70 parts of radix rehmanniae preparata, 50-70 parts of dried radix rehmanniae, 50-70 parts of cortex lycii radicis, 50-70 parts of fructus lycii, 50-70 parts of radix ophiopogonis, 50-70 parts of gypsum, 50-70 parts of Chinese yam, 50-70 parts of white peony root, 50-70 parts of rhizoma anemarrhenae, 50-70 parts of coptidis rhizome, 50-70 parts of stiff silkworm, 50-70 parts of fructus schizandrae, 50-70 parts of radix pseudostellariae, 50-70 parts of pseudo-ginseng, 50-70 parts of salviae miltiorrhizae, 50-70 parts of radix glehniae, 50-70 parts of radix puerariae edulis, 25-35 parts of cortex cinnamomi, 50-70 parts of red ginseng, 50-70 parts of semen litchi, 45-55 parts of resina draconis, 50-70 parts of common fenugreek seed and one or more of 50-70 parts of radix astragali, 50-70 parts of radix polygonati officinalis, 50-70 parts of rhizoma polygonatum or 50-70 parts of dendrobium nobile. The drug employs an optimized and selected combination of traditional Chinese medicine formula to obtain a drug which is suitable for most of diabetes. The drug has good curative effect, fast effectiveness and small side effect. The drug is low in cost and easy to prepare, and has very ideal usage effect.
Description
Technical field
The present invention relates to a kind of medicine, particularly a kind of medicine for the treatment of diabetes.
Background technology
Diabetes (Diabetes mellitus DM) are the chronic disease of a kind of complex disease because causing, mainly due to sugar, fat, protein metabolism disorder in body, clinically take blood glucose to increase with glycosuria be feature, and then can cause the synthetic disease of multisystem, many organ injuries, as diabetes merge cardiovascular, kidney; Retina and neural pathological changes, the diseases such as diabetic ketoacidosis.Being divided into clinically insulin-dependent and non-insulin-dependent diabetes mellitus (is type Ⅱdiabetes mellitus Non-Insulin Depeudent Dia betes Meuitus, NIDDM), model case many with can there is polyuria, polydipsia, polyphagia, become thin, the performance such as tired, primary disease belongs to " quenching one's thirst " category of Chinese medicine.
Along with the raising of living standards of the people,, increasing of the quickening of rhythm of life and nutrition absorption is even superfluous, the sickness rate of China's diabetes is constantly soaring, and number of patients has become a startling numeral.Diabetes and complication thereof just China people's healthy and life security in serious harm.Modern medicine it is generally acknowledged that diabetes are relevant with many factors such as body insulin deficit, insulin resistant, inherited genetic factors, hormonal readinesses, the medicines such as main application oral antidiabetic drug, euglycemic agent are treated, most of Western medicine action pathway are single, very easily cause patient's hypoglycemia, islet beta cell function exhaustion and other are as side effect such as edema, liver injury, the possibility that long-term taking needs dosage and has secondary to lose efficacy, Western medicine can not be controlled chronic complicating diseases effectively in addition.Therefore the application limitations of such chemicals is more.
Modern Chinese medicine treatment diabetes are under the guidance of differentiation of symptoms and signs for classification of syndrome thinking, use the methods such as nourishing YIN and clearing away heat, supplementing QI and nourishing YIN, blood circulation promoting and blood stasis dispelling, kidney and spleen invigorating, depressed liver-energy dispersing and QI regulating, benefiting QI for activating blood circulation, invigorating kidney, promoting blood circulation, wherein take invigorating the spleen and replenishing QI, heat clearing away YIN nourishing, blood circulation promoting and blood stasis dispelling is rule for the treatment of.Because compound of Chinese medicine can reach giving consideration to both the incidental and fundamental, in treatment primary symptom, effectively prevent and treat the complication of diabetes, and its mechanism of action and approach show as polytropism, multi-level pharmacology, be difficult for producing the situations such as insulin resistant, the advantage of compound of Chinese medicine diabetes and complication day by day manifests.At present know after deliberation have the Chinese medicine of definite curative effect to mainly contain Radix Panacis Quinquefolii, Radix Ginseng, the Radix Astragali, Radix Salviae Miltiorrhizae, Radix Notoginseng, the Radix Rehmanniae, Radix Rehmanniae Preparata, Fructus Lycii, Herba Dendrobii, Radix Et Rhizoma Rhei, Herb Gynostemmae Pentaphylli, Herba Potentillae Discoloris etc.For diabetes and complication, the single medicinal material that can select is a lot, but need select the different rule for the treatment of according to clinical syndrome differentiation, so the scope of application is subject to very big limitation.
Summary of the invention
Technical problem to be solved by this invention is: a kind of medicine for the treatment of diabetes is provided, and its side effect is little, and good effect is applied widely, to overcome the deficiencies in the prior art.
The medicine that is achieved in that treatment diabetes of the present invention, calculate by weight, comprise 50～70 parts of Radix Trichosanthis, 50～70 parts, Poria, 50～70 parts, Radix Rehmanniae Preparata, 50～70 parts, the Radix Rehmanniae, 50～70 parts of Cortex Lycii, 50～70 parts of Fructus Lyciis, 50～70 parts of Radix Ophiopogonis, 50～70 parts, Gypsum Fibrosum, 50～70 parts of Rhizoma Dioscoreaes, 50～70 parts of the Radix Paeoniae Albas, 25～35 parts of the Rhizoma Anemarrhenaes, 50～70 parts of Rhizoma Coptidis, 50～70 parts of Bombyx Batryticatus, 25～35 parts of Fructus Schisandrae Chinensis, 50～70 parts of Radix Pseudostellariaes, 90～110 parts of Radix Notoginseng, 50～70 parts of Radix Salviae Miltiorrhizaes, 50～70 parts of Radix Glehniaes, 50～70 parts of Pachyrhizua angulatus, 25～35 parts of Cortex Cinnamomis, 50～70 parts of Radix Ginseng Rubra, 50～70 parts of Semen Litchis, 50～70 parts of 45～55 parts of Sanguis Draxonis and Semen Trigonellaes, and at least comprise more than one in 50～70 parts of 50～70 parts of the Radixs Astragali, 50～70 parts of Rhizoma Polygonati Odorati, 50～70 parts of Rhizoma Polygonatis or Herba Dendrobiis.
Preferred scheme is, calculate by weight, comprise 60 parts of 60 parts of Radix Trichosanthis, 60 parts, Poria, 60 parts, Radix Rehmanniae Preparata, 60 parts, the Radix Rehmanniae, 60 parts of Cortex Lycii, 60 parts of Fructus Lyciis, 60 parts of Radix Ophiopogonis, 60 parts, Gypsum Fibrosum, 60 parts of Rhizoma Dioscoreaes, 60 parts of the Radix Paeoniae Albas, 30 parts of the Rhizoma Anemarrhenaes, 60 parts of Rhizoma Coptidis, 60 parts of Bombyx Batryticatus, 30 parts of Fructus Schisandrae Chinensis, 60 parts of Radix Pseudostellariaes, 100 parts of Radix Notoginseng, 60 parts of Radix Salviae Miltiorrhizaes, 60 parts of Radix Glehniaes, 60 parts of Pachyrhizua angulatus, 30 parts of Cortex Cinnamomis, 60 parts of Radix Ginseng Rubra, 60 parts of Semen Litchis, 50 parts of Sanguis Draxonis and Semen Trigonellaes; And at least comprise more than one in 60 parts of 60 parts of the Radixs Astragali, 60 parts of Rhizoma Polygonati Odorati, 60 parts of Rhizoma Polygonatis or Herba Dendrobiis.
The preparation method of the medicine for the treatment of diabetes, getting Radix Trichosanthis, Rhizoma Polygonati Odorati, the Radix Astragali, Poria, Radix Rehmanniae Preparata, the Radix Rehmanniae, Cortex Lycii, Fructus Lycii, Radix Ophiopogonis, Gypsum Fibrosum, Rhizoma Dioscoreae, the Radix Paeoniae Alba, the Rhizoma Anemarrhenae, Herba Dendrobii, Rhizoma Coptidis, Bombyx Batryticatus, Fructus Schisandrae Chinensis, Rhizoma Polygonati, Radix Pseudostellariae, Radix Notoginseng, Radix Salviae Miltiorrhizae, Radix Glehniae, Pachyrhizua angulatus, Cortex Cinnamomi, Radix Ginseng Rubra, Semen Litchi, Sanguis Draxonis and Semen Trigonellae mixes, mixture is pulverized, get 7～9 grams of encapsulation of comminuting matter, make Chinese medicine powder.
Mixed material is crossed 100 mesh sieves after pulverizing.
The preparation method of the medicine for the treatment of diabetes, gets Radix Notoginseng and pulverizes standby, get again Radix Trichosanthis, Rhizoma Polygonati Odorati, the Radix Astragali, Poria, Radix Rehmanniae Preparata, the Radix Rehmanniae, Cortex Lycii, Fructus Lycii, Radix Ophiopogonis, Gypsum Fibrosum, Rhizoma Dioscoreae, the Radix Paeoniae Alba, the Rhizoma Anemarrhenae, Herba Dendrobii, Rhizoma Coptidis, Bombyx Batryticatus, Fructus Schisandrae Chinensis, Rhizoma Polygonati, Radix Pseudostellariae, Radix Salviae Miltiorrhizae, Radix Glehniae, Pachyrhizua angulatus, Cortex Cinnamomi, Radix Ginseng Rubra, Semen Litchi, Sanguis Draxonis and Semen Trigonellae mix, in mixture, add the water of 10～15 parts to decoct 1 hour by weight for the first time, add respectively again the decocting of 8～12 times of weight to boil twice, each decoction 35 minutes, merge decoction liquor and filter, filtrate is concentrated into thick shape again, then after cooling, add Radix Notoginseng powder to mix, make Chinese medicine preparation.
After adding Radix Notoginseng powder to mix, at 80 ℃, carry out pulverizing after drying under reduced pressure, cross 60 mesh sieves, incapsulate shell, make hard capsule.
In order to verify effect of the present invention, medicine finished product has been carried out to clinical trial, its result is as follows:
From 2006 to 2011, use this kind of drug treatment of diabetic 459 examples, women's 255 examples, male's 204 examples, in mean age 43-61 year, the course of disease is the longest 8 years the shortest half a year, and 80% left and right case concentrates on 5 years courses of disease.Upper elimination type 102 examples wherein, in side Radix Trichosanthis, Rhizoma Coptidis, Radix Ophiopogonis etc. compatibility can promoting the production of body fluid to quench thirst again can resolving heat and reducing pathogenic fire, play clearing heat and moistening lung, promoting the production of body fluid to quench thirst effect, treat and test blood sugar level after three months, there are more obvious descender's 100 examples, 1 routine blood sugar level declines slightly, and 1 routine insulin resistant patient is invalid.In type 281 examples that disappear, the heat of Gypsum Fibrosum, Rhizoma Anemarrhenae lung heat clearing stomach in side; Radix Rehmanniae, Radix Ophiopogonis lung benefiting stomach the moon, eliminating stomach-fire, the effect of YIN supplementing and fluids increasing play in full side, treat blood glucose average level after five months and reach normal level 252 examples, decline but still more higher person's 17 examples, total effective rate 95.7%, 9 examples of remaininging in 12 examples are thirsty and be hard and dry etc., and symptom is alleviated to some extent.Under type 76 examples (deficiency of both YIN and YANG 3 examples that disappear, deficiency of kidney-YIN 73 examples), after treating half a year, test result shows effective 76 examples, average fasting glucose 12.6mmol/L before treatment, post-prandial glycemia 17.1 mmol/L, average fasting glucose 7.6 mmol/L after treatment, post-prandial glycemia 11.0 mmol/L, decline respectively 39.7% and 35.7%.In above-mentioned all types of case therapeutic process, complication rate significantly lowers.
Model case
1, history so-and-so: man, 50 years old age, live Xiaohe District, Guiyang, from 3 monthly tests in 2007, find and suffer from diabetes, fasting glucose is 14.5mmol/L, post-prandial glycemia is 19.1 mmol/L.From in JIUYUE, 2007, start to take medicine of the present invention 5 months, again remove examination in hospital in February, 2008, its fasting glucose of result is 8.5mmol/L, and post-prandial glycemia is 12.1 mmol/L.
2, Song: female, 54 years old age, live Nanming District, Guiyang, from 7 monthly tests in 2005, to find and suffer from diabetes, fasting glucose is 13.3mmol/L, post-prandial glycemia is 17.5 mmol/L.From in December, 2008, start to take medicine of the present invention 5 months, again remove examination in hospital in May, 2009, its fasting glucose of result is 6.9mmol/L, and post-prandial glycemia is 10.5 mmol/L.
3, business so-and-so: man, 60 years old age, live Nanming District, Guiyang, from 7 monthly tests in 2006, find and suffer from diabetes, fasting glucose is 12.1mmol/L, post-prandial glycemia is 16.7mmol/L.From in March, 2007, start to take medicine of the present invention 3 months, again removing examination in hospital, its fasting glucose in November, 2007 is 7.3mmol/L, and post-prandial glycemia is 10.5 mmol/L.
4, Jiang: man, 45 years old age, live Yunyan District, Guiyang, 3 monthly tests in 2009 are found suffers from diabetes, and fasting glucose is 11.5mmol/L, and post-prandial glycemia is 15.8 mmol/L.From in April, 2010, start to take medicine of the present invention 3 months, again remove examination in hospital in August, 2010, its fasting glucose of result is 6.5mmol/L, and post-prandial glycemia is 10.3mmol/L.
5, deep so-and-so: female, 48 years old age, live Zunyi City, Guizhou Province, 10 monthly tests in 2008 are found suffers from diabetes, fasting glucose is 13.4mmol/L, post-prandial glycemia is 17.5 mmol/L.From in October, 2009, start to take medicine of the present invention 5 months, again remove examination in hospital in June, 2010, its fasting glucose of result is 8.1mmol/L, and post-prandial glycemia is 12.4 mmol/L.
According to the therapeutic outcome of model case, can find out, the present invention has comparatively significant hypoglycemic activity to treatment diabetics, and curative effect is fast, and because the Chinese medicinal components collocation adopting is reasonable, so side effect is little.
Owing to having adopted technique scheme, compared with prior art, the present invention adopts the screening combination that Chinese medicine formula is optimized, and obtains a kind of medicine that can be applicable to most of glycosuria patients, and this curative effect of medication is good, instant effect, and also side effect is little.The present invention is with low cost, easily implements, and result of use is very good.
The specific embodiment
Embodiments of the invention 1: the medicine for the treatment of diabetes, get 60 parts of Radix Trichosanthis, 60 parts of Rhizoma Polygonati Odorati, 60 parts of the Radixs Astragali, 60 parts, Poria, 60 parts, Radix Rehmanniae Preparata, 60 parts, the Radix Rehmanniae, 60 parts of Cortex Lycii, 60 parts of Fructus Lyciis, 60 parts of Radix Ophiopogonis, 60 parts, Gypsum Fibrosum, 60 parts of Rhizoma Dioscoreaes, 60 parts of the Radix Paeoniae Albas, 30 parts of the Rhizoma Anemarrhenaes, 60 parts of Herba Dendrobiis, 60 parts of Rhizoma Coptidis, 60 parts of Bombyx Batryticatus, 30 parts of Fructus Schisandrae Chinensis, 60 parts of Rhizoma Polygonatis, 60 parts of Radix Pseudostellariaes, 100 parts of Radix Notoginseng, 60 parts of Radix Salviae Miltiorrhizaes, 60 parts of Radix Glehniaes, 60 parts of Pachyrhizua angulatus, 30 parts of Cortex Cinnamomis, 60 parts of Radix Ginseng Rubra, 60 parts of Semen Litchis, 60 parts of mixing of 50 parts of Sanguis Draxonis and Semen Trigonellae, then with machinery, pulverize, mixed material is crossed 100 orders after pulverizing, get 7～9 grams of encapsulation of comminuting matter, make Chinese medicine powder.At morning every day, supper, within first 20 minutes, take.
Embodiments of the invention 2: the medicine for the treatment of diabetes, get 60 parts of Radix Trichosanthis, 60 parts of Rhizoma Polygonati Odorati, 60 parts, Poria, 60 parts, Radix Rehmanniae Preparata, 60 parts, the Radix Rehmanniae, 60 parts of Cortex Lycii, 60 parts of Fructus Lyciis, 60 parts of Radix Ophiopogonis, 60 parts, Gypsum Fibrosum, 60 parts of Rhizoma Dioscoreaes, 60 parts of the Radix Paeoniae Albas, 30 parts of the Rhizoma Anemarrhenaes, 60 parts of Rhizoma Coptidis, 60 parts of Bombyx Batryticatus, 30 parts of Fructus Schisandrae Chinensis, 60 parts of Radix Pseudostellariaes, 100 parts of Radix Notoginseng, 60 parts of Radix Salviae Miltiorrhizaes, 60 parts of Radix Glehniaes, 60 parts of Pachyrhizua angulatus, 30 parts of Cortex Cinnamomis, 60 parts of Radix Ginseng Rubra, 60 parts of Semen Litchis, 50 parts of Sanguis Draxonis and 60 parts of mixing of Semen Trigonellae; Then in mixture, add the water of 10～15 parts to decoct 1 hour by weight for the first time, add respectively again the decocting of 8～12 times of weight to boil twice, each decoction 35 minutes, merge decoction liquor and filter, filtrate is concentrated into thick shape again, then after cooling, add Radix Notoginseng powder to mix, make Chinese medicine preparation.At morning every day, supper, within first 20 minutes, take.
Embodiments of the invention 3: the medicine for the treatment of diabetes, get 60 parts of Radix Trichosanthis, 60 parts of Rhizoma Polygonati Odorati, 60 parts, Poria, 60 parts, Radix Rehmanniae Preparata, 60 parts, the Radix Rehmanniae, 60 parts of Cortex Lycii, 60 parts of Fructus Lyciis, 60 parts of Radix Ophiopogonis, 60 parts, Gypsum Fibrosum, 60 parts of Rhizoma Dioscoreaes, 60 parts of the Radix Paeoniae Albas, 30 parts of the Rhizoma Anemarrhenaes, 60 parts of Rhizoma Coptidis, 60 parts of Bombyx Batryticatus, 30 parts of Fructus Schisandrae Chinensis, 60 parts of Radix Pseudostellariaes, 100 parts of Radix Notoginseng, 60 parts of Radix Salviae Miltiorrhizaes, 60 parts of Radix Glehniaes, 60 parts of Pachyrhizua angulatus, 30 parts of Cortex Cinnamomis, 60 parts of Radix Ginseng Rubra, 60 parts of Semen Litchis, 50 parts of Sanguis Draxonis and 60 parts of mixing of Semen Trigonellae; Then in mixture, add the water of 10～15 parts to decoct 1 hour by weight for the first time, add respectively again the decocting of 8～12 times of weight to boil twice, decoct 35 minutes at every turn, merge decoction liquor and filter, filtrate is concentrated into thick shape again, adds Radix Notoginseng powder to mix after then cooling; At 80 ℃, carry out pulverizing after drying under reduced pressure, cross 60 mesh sieves, incapsulate shell, make hard capsule.At morning every day, supper, within first 20 minutes, take.
Claims (6)
1. a medicine for the treatment of diabetes, it is characterized in that: calculate by weight, by 50～70 parts of Radix Trichosanthis, 50～70 parts, Poria, 50～70 parts, Radix Rehmanniae Preparata, 50～70 parts, the Radix Rehmanniae, 50～70 parts of Cortex Lycii, 50～70 parts of Fructus Lyciis, 50～70 parts of Radix Ophiopogonis, 50～70 parts, Gypsum Fibrosum, 50～70 parts of Rhizoma Dioscoreaes, 50～70 parts of the Radix Paeoniae Albas, 25～35 parts of the Rhizoma Anemarrhenaes, 50～70 parts of Rhizoma Coptidis, 50～70 parts of Bombyx Batryticatus, 25～35 parts of Fructus Schisandrae Chinensis, 50～70 parts of Radix Pseudostellariaes, 90～110 parts of Radix Notoginseng, 50～70 parts of Radix Salviae Miltiorrhizaes, 50～70 parts of Radix Glehniaes, 50～70 parts of Pachyrhizua angulatus, 25～35 parts of Cortex Cinnamomis, 50～70 parts of Radix Ginseng Rubra, 50～70 parts of Semen Litchis, 45～55 parts of Sanguis Draxonis, 50～70 parts of Semen Trigonellaes, and comprise 50～70 parts of the Radixs Astragali, 50～70 parts of Rhizoma Polygonati Odorati, more than one in 50～70 parts of 50～70 parts of Rhizoma Polygonatis or Herba Dendrobiis are made.
2. the medicine for the treatment of diabetes according to claim 1, it is characterized in that: calculate by weight, by 60 parts of Radix Trichosanthis, 60 parts, Poria, 60 parts, Radix Rehmanniae Preparata, 60 parts, the Radix Rehmanniae, 60 parts of Cortex Lycii, 60 parts of Fructus Lyciis, 60 parts of Radix Ophiopogonis, 60 parts, Gypsum Fibrosum, 60 parts of Rhizoma Dioscoreaes, 60 parts of the Radix Paeoniae Albas, 30 parts of the Rhizoma Anemarrhenaes, 60 parts of Rhizoma Coptidis, 60 parts of Bombyx Batryticatus, 30 parts of Fructus Schisandrae Chinensis, 60 parts of Radix Pseudostellariaes, 100 parts of Radix Notoginseng, 60 parts of Radix Salviae Miltiorrhizaes, 60 parts of Radix Glehniaes, 60 parts of Pachyrhizua angulatus, 30 parts of Cortex Cinnamomis, 60 parts of Radix Ginseng Rubra, 60 parts of Semen Litchis, 50 parts of Sanguis Draxonis, 60 parts of Semen Trigonellaes, and comprise 60 parts of the Radixs Astragali, 60 parts of Rhizoma Polygonati Odorati, more than one in 60 parts of 60 parts of Rhizoma Polygonatis or Herba Dendrobiis are made.
3. the preparation method of the medicine for the treatment of diabetes as claimed in claim 1, it is characterized in that: by above-mentioned parts by weight, getting Radix Trichosanthis, Rhizoma Polygonati Odorati, the Radix Astragali, Poria, Radix Rehmanniae Preparata, the Radix Rehmanniae, Cortex Lycii, Fructus Lycii, Radix Ophiopogonis, Gypsum Fibrosum, Rhizoma Dioscoreae, the Radix Paeoniae Alba, the Rhizoma Anemarrhenae, Herba Dendrobii, Rhizoma Coptidis, Bombyx Batryticatus, Fructus Schisandrae Chinensis, Rhizoma Polygonati, Radix Pseudostellariae, Radix Notoginseng, Radix Salviae Miltiorrhizae, Radix Glehniae, Pachyrhizua angulatus, Cortex Cinnamomi, Radix Ginseng Rubra, Semen Litchi, Sanguis Draxonis and Semen Trigonellae mixes, mixture is pulverized, get 7～9 grams of encapsulation of comminuting matter, make Chinese medicine powder.
4. the preparation method of the medicine for the treatment of diabetes according to claim 3, is characterized in that: mixed material is crossed 100 mesh sieves after pulverizing.
5. a preparation method for the medicine for the treatment of diabetes as claimed in claim 1, is characterized in that: by above-mentioned parts by weight, get Radix Notoginseng and pulverize standby, get again Radix Trichosanthis, Rhizoma Polygonati Odorati, the Radix Astragali, Poria, Radix Rehmanniae Preparata, the Radix Rehmanniae, Cortex Lycii, Fructus Lycii, Radix Ophiopogonis, Gypsum Fibrosum, Rhizoma Dioscoreae, the Radix Paeoniae Alba, the Rhizoma Anemarrhenae, Herba Dendrobii, Rhizoma Coptidis, Bombyx Batryticatus, Fructus Schisandrae Chinensis, Rhizoma Polygonati, Radix Pseudostellariae, Radix Salviae Miltiorrhizae, Radix Glehniae, Pachyrhizua angulatus, Cortex Cinnamomi, Radix Ginseng Rubra, Semen Litchi, Sanguis Draxonis and Semen Trigonellae mix, multiple adds the water of 10～15 times to decoct 1 hour in mixture by weight for the first time, add respectively again the decocting of 8～12 times of weight to boil twice, each decoction 35 minutes, merge decoction liquor and filter, again filtrate is concentrated into thick shape, then after cooling, add Radix Notoginseng powder to mix, make Chinese medicine preparation.
6. according to the preparation method of the medicine for the treatment of diabetes claimed in claim 5, it is characterized in that: after adding Radix Notoginseng powder to mix, at 80 ℃, carry out pulverizing after drying under reduced pressure, cross 60 mesh sieves, incapsulate shell, make hard capsule.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201110330663.6A CN103083531B (en) | 2011-10-27 | 2011-10-27 | Drug for treating diabetes |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201110330663.6A CN103083531B (en) | 2011-10-27 | 2011-10-27 | Drug for treating diabetes |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103083531A CN103083531A (en) | 2013-05-08 |
| CN103083531B true CN103083531B (en) | 2014-10-15 |
Family
ID=48197010
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201110330663.6A Expired - Fee Related CN103083531B (en) | 2011-10-27 | 2011-10-27 | Drug for treating diabetes |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103083531B (en) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103271402B (en) * | 2013-05-31 | 2014-07-30 | 姬文勤 | Functional beverage for reducing blood sugar |
| CN103599411B (en) * | 2013-11-19 | 2016-04-13 | 太和县中医院 | A kind of Chinese medicine for the treatment of diabetes |
| CN103768489B (en) * | 2013-12-30 | 2016-03-02 | 于义琴 | A kind of diabetes injection care drug and preparation method thereof |
| CN103721074B (en) * | 2014-01-15 | 2017-01-18 | 四川万安石斛产业开发有限公司 | Pharmaceutical composition and preparation method and application thereof |
| CN103735843A (en) * | 2014-01-29 | 2014-04-23 | 唐树青 | Medicine composition for treating diabetes |
| CN104225361A (en) * | 2014-09-05 | 2014-12-24 | 刘委 | Health wine with radix salviae miltiorrhizae and pseudo-ginseng and preparation method of health wine |
| CN104721580A (en) * | 2015-03-03 | 2015-06-24 | 刘正菊 | Traditional Chinese medicine composition for treating diabetes |
| CN105796874A (en) * | 2016-03-03 | 2016-07-27 | 刘桂荣 | Formula and preparation method of compound medicine for treating diabetes |
| CN105878668A (en) * | 2016-06-24 | 2016-08-24 | 贵州盛世保康茶开发有限公司 | Capsule for treating diabetes |
| CN105998956A (en) * | 2016-07-01 | 2016-10-12 | 覃益祥 | Traditional Chinese medicine composition for treating diabetes |
| CN106266693A (en) * | 2016-08-31 | 2017-01-04 | 李朝彬 | The Chinese medicine composition for the treatment of diabetes |
| CN106377695A (en) * | 2016-11-15 | 2017-02-08 | 河南中医药大学 | Traditional Chinese medicine composition capable of reducing blood sugar |
| CN106692780B (en) * | 2016-12-23 | 2020-01-14 | 淄博亚大制药股份有限公司 | Composition for preventing and relieving diabetes and complications thereof |
| CN107441406A (en) * | 2017-08-16 | 2017-12-08 | 武汉钧安制药有限公司 | Treat Chinese medicine preparation of type II diabetes and preparation method thereof |
| CN110787258A (en) * | 2019-11-27 | 2020-02-14 | 王同生 | A Chinese medicinal composition for treating diabetes, and its preparation method |
| CN111494562A (en) * | 2020-06-19 | 2020-08-07 | 高艺桐 | A Chinese medicinal composition for treating diabetes, and its preparation method |
| CN117137988A (en) * | 2023-10-31 | 2023-12-01 | 农安仁济医院 | Traditional Chinese medicine composition and preparation method and application thereof |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1235551A (en) * | 1996-11-01 | 1999-11-17 | 参天堂制药株式会社 | Pharmaceutical composition for treating diabetes |
| CN101708295A (en) * | 2009-12-04 | 2010-05-19 | 卢速江 | Chinese medicinal preparation for treating diabetes and preparation methods thereof |
| CN101708302A (en) * | 2009-12-08 | 2010-05-19 | 张为举 | Chinese medicinal preparation for treating diabetes and preparation method thereof |
-
2011
- 2011-10-27 CN CN201110330663.6A patent/CN103083531B/en not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1235551A (en) * | 1996-11-01 | 1999-11-17 | 参天堂制药株式会社 | Pharmaceutical composition for treating diabetes |
| CN101708295A (en) * | 2009-12-04 | 2010-05-19 | 卢速江 | Chinese medicinal preparation for treating diabetes and preparation methods thereof |
| CN101708302A (en) * | 2009-12-08 | 2010-05-19 | 张为举 | Chinese medicinal preparation for treating diabetes and preparation method thereof |
Non-Patent Citations (4)
| Title |
|---|
| 中医药治疗2 型糖尿病胰岛素抵抗用药分析;莫娜等;《陕西中医》;20091231;第30卷(第1期);第88-90页 * |
| 常文治.降糖汤治疗非胰岛素依赖型糖尿病60例.《河南中医》.2007,第27卷(第2期),第48页. |
| 莫娜等.中医药治疗2 型糖尿病胰岛素抵抗用药分析.《陕西中医》.2009,第30卷(第1期),第88-90页. |
| 降糖汤治疗非胰岛素依赖型糖尿病60例;常文治;《河南中医》;20070228;第27卷(第2期);第48页 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103083531A (en) | 2013-05-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103083531B (en) | Drug for treating diabetes | |
| CN102274447B (en) | Medicinal composition for treating diabetes | |
| CN103566350B (en) | A kind of pharmaceutical composition with hypoglycemic effect | |
| CN101874874B (en) | Chinese medicinal preparation for treating helicobacter pylori concerned chronic gastritis and preparation method thereof | |
| CN100353983C (en) | Chinese medicine preparation for reducing sugar | |
| CN102284049A (en) | Traditional Chinese medicine compound preparation for resisting ulcer and relieving chemoradiotherapeutic toxic and side effects, and preparation method and application thereof | |
| CN103920028A (en) | Pharmaceutical composition for treating diabetes and preparation method of preparation thereof | |
| CN101125173A (en) | Traditional Chinese medicine 'guiyuantangkang' for treating diabetes and its complication | |
| CN104815166B (en) | A kind of Chinese medicine composition for treating diabetes and its preparation and application | |
| CN102698058B (en) | Health care extract for adjusting sub-healthy state of human body | |
| CN101279034B (en) | Combined Chinese medicament for curing diabetic with combined internal and external therapies and preparation thereof | |
| CN1173726C (en) | Medicine for curing malignant turnor and its preparation method | |
| CN102940782A (en) | Chinese medicinal composition for reducing blood sugar | |
| CN102114189A (en) | Chinese medicinal blood glucose reducing tablet for treating diabetes comprising superfine powder | |
| CN102488830A (en) | Pharmaceutical composition for lowering blood sugar | |
| CN101411770B (en) | Medicament for treating blood stasis accumulation type multiple sclerosis symptoms | |
| CN103599343A (en) | Pharmaceutical composition for treating diabetes, and preparation method and application thereof | |
| CN101987132A (en) | Medicament for treating acne and preparation method thereof | |
| CN103263580A (en) | A kind of traditional Chinese medicine composition for treating diabetes | |
| CN105055967A (en) | Compound health care product having auxiliary blood sugar reducing function and preparation method | |
| CN103520684A (en) | Traditional Chinese medicine compound for reducing blood sugar | |
| CN103599386B (en) | A kind of Chinese medicine composition for diabetes | |
| CN117045764B (en) | Traditional Chinese medicine composition for treating type II diabetes and preparation method thereof | |
| CN103263595A (en) | Traditional Chinese medicine composition for treating diabetes | |
| CN103566349A (en) | Medicinal composition for treating hyperglycemia and hyperlipidemia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Free format text: FORMER OWNER: DING RUIYI Effective date: 20150316 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20150316 Address after: Songshan District 550001 in Guizhou province Guiyang City Road 2 Building 2 Linglong wisdom dragon waterside unit 10 floor No. 1 Patentee after: Peng Zhuyan Address before: Songshan District 550001 in Guizhou province Guiyang City Road 2 Building 2 Linglong wisdom dragon waterside unit 10 floor No. 1 Patentee before: Peng Zhuyan Patentee before: Ding Ruiyi |
|
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20141015 Termination date: 20181027 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |